These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32674668)

  • 1. Perceived harm, motivations for use and subjective experiences of recreational psychedelic 'magic' mushroom use.
    Roberts CA; Osborne-Miller I; Cole J; Gage SH; Christiansen P
    J Psychopharmacol; 2020 Sep; 34(9):999-1007. PubMed ID: 32674668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magic Mushroom Use: A Qualitative Interview Study of Post-Trip Impacts and Strategies for Optimizing Experiences.
    Shaw L; Rea K; Lachowsky NJ; Roth EA
    J Psychoactive Drugs; 2023; 55(2):151-158. PubMed ID: 35315749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms.
    Kopra EI; Ferris JA; Winstock AR; Young AH; Rucker JJ
    J Psychopharmacol; 2022 Aug; 36(8):965-973. PubMed ID: 35388724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Turn on, tune in, but don't drop out: The impact of neo-liberalism on magic mushroom users' (in)ability to imagine collectivist social worlds.
    Riley S; Thompson J; Griffin C
    Int J Drug Policy; 2010 Nov; 21(6):445-51. PubMed ID: 20810266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students.
    Hallock RM; Dean A; Knecht ZA; Spencer J; Taverna EC
    Drug Alcohol Depend; 2013 Jun; 130(1-3):245-8. PubMed ID: 23265089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magic Mushrooms - an exploratory look at how mental health professionals feel and think about Psilocybin.
    Meyer TD; Meir P; Lex C; Soares JC
    Psychiatry Res; 2022 Oct; 316():114727. PubMed ID: 35878481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA Authentication and Chemical Analysis of
    Bradshaw AJ; Backman TA; Ramírez-Cruz V; Forrister DL; Winter JM; Guzmán-Dávalos L; Furci G; Stamets P; Dentinger BTM
    Appl Environ Microbiol; 2022 Dec; 88(24):e0149822. PubMed ID: 36445079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes.
    Nkadimeng SM; Steinmann CML; Eloff JN
    Sci Rep; 2020 Dec; 10(1):22314. PubMed ID: 33339902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DARK Classics in Chemical Neuroscience: Psilocybin.
    Geiger HA; Wurst MG; Daniels RN
    ACS Chem Neurosci; 2018 Oct; 9(10):2438-2447. PubMed ID: 29956917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Consumption of psilocybin-containing hallucinogenic mushrooms by young people].
    Lassen JF; Lassen NF; Skov J
    Ugeskr Laeger; 1992 Sep; 154(39):2678-81. PubMed ID: 1413197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy.
    Sumnall HR; Cole JC; Jerome L
    J Psychopharmacol; 2006 Sep; 20(5):670-82. PubMed ID: 16401654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hallucinogenic mushrooms].
    Reingardiene D; Vilcinskaite J; Lazauskas R
    Medicina (Kaunas); 2005; 41(12):1067-70. PubMed ID: 16401965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of 'magic mushroom' consumption.
    Morton E; Sakai K; Ashtari A; Pleet M; Michalak EE; Woolley J
    J Psychopharmacol; 2023 Jan; 37(1):49-60. PubMed ID: 36515370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response relationships of psilocybin-induced subjective experiences in humans.
    Hirschfeld T; Schmidt TT
    J Psychopharmacol; 2021 Apr; 35(4):384-397. PubMed ID: 33663259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peculiar plants and fantastic fungi: An ethnobotanical study of the use of hallucinogenic plants and mushrooms in Slovenia.
    Fatur K
    PLoS One; 2021; 16(1):e0245022. PubMed ID: 33412556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poisonings resulting from the ingestion of magic mushrooms in Kraków.
    Satora L; Goszcz H; Ciszowski K
    Przegl Lek; 2005; 62(6):394-6. PubMed ID: 16225077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hallucinogenic psilocybine containing mushrooms. Toxins contained in Danish wild mushrooms].
    Lassen JF; Ravn HB; Lassen SF
    Ugeskr Laeger; 1990 Jan; 152(5):314-7. PubMed ID: 2301080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.
    Carbonaro TM; Bradstreet MP; Barrett FS; MacLean KA; Jesse R; Johnson MW; Griffiths RR
    J Psychopharmacol; 2016 Dec; 30(12):1268-1278. PubMed ID: 27578767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microdosing psychedelics: Motivations, subjective effects and harm reduction.
    Lea T; Amada N; Jungaberle H; Schecke H; Klein M
    Int J Drug Policy; 2020 Jan; 75():102600. PubMed ID: 31778967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of phenylethylamine in hallucinogenic Psilocybe mushroom: possible role in adverse reactions.
    Beck O; Helander A; Karlson-Stiber C; Stephansson N
    J Anal Toxicol; 1998; 22(1):45-9. PubMed ID: 9491968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.